WO2008148074A3 - Inhibitors of mtor and methods of treatment using same - Google Patents
Inhibitors of mtor and methods of treatment using same Download PDFInfo
- Publication number
- WO2008148074A3 WO2008148074A3 PCT/US2008/064809 US2008064809W WO2008148074A3 WO 2008148074 A3 WO2008148074 A3 WO 2008148074A3 US 2008064809 W US2008064809 W US 2008064809W WO 2008148074 A3 WO2008148074 A3 WO 2008148074A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- methods
- mtor
- inhibitors
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
The present invention provides novel compounds that inhibit mTOR activity. Compositions, including pharmaceutical compositions, comprising compounds of the present invention are also provided. The present invention also provides methods of treatment comprising administering compositions of the present invention to a subject in need thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93185807P | 2007-05-24 | 2007-05-24 | |
US60/931,858 | 2007-05-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008148074A2 WO2008148074A2 (en) | 2008-12-04 |
WO2008148074A3 true WO2008148074A3 (en) | 2009-03-19 |
Family
ID=40075755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/064809 WO2008148074A2 (en) | 2007-05-24 | 2008-05-24 | Inhibitors of mtor and methods of treatment using same |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008148074A2 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2710039C (en) | 2007-12-26 | 2018-07-03 | Critical Outcome Technologies, Inc. | Semicarbazones, thiosemicarbazones and related compounds and methods for treatment of cancer |
CA2730890C (en) | 2008-07-17 | 2018-05-15 | Critical Outcome Technologies Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
AU2010267814B2 (en) * | 2009-07-02 | 2015-07-16 | Sanofi | Novel 2,3-dihydro-1H-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof |
FR2951173B1 (en) * | 2009-10-09 | 2011-12-02 | Sanofi Aventis | NOVEL 2,3-DIHYDRO-1H-IMIDAZO {1,2-A} PYRIMIDIN-5-ONE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AS AKT PHOSPHORYLATION INHIBITORS (PKB) |
FR2951174B1 (en) * | 2009-10-09 | 2011-12-02 | Sanofi Aventis | NOVEL 1,2,3,4-TETRAHYDRO-PYRIMIDO {1,2-A} PYRIMIDIN-6-ONE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AS AKT PHOSPHORYLATION INHIBITORS (PKB) |
FR2947550B1 (en) * | 2009-07-02 | 2012-05-18 | Sanofi Aventis | NOVEL 2,3-DIHYDRO-1H-IMIDAZO {1,2-A} PYRIMIDIN-5-ONE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AS AKT PHOSPHORYLATION INHIBITORS (PKB) |
US8846670B2 (en) * | 2009-07-02 | 2014-09-30 | Sanofi | 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof |
FR2947551B1 (en) * | 2009-07-02 | 2012-05-18 | Sanofi Aventis | NOVEL 1,2,3,4-TETRAHYDRO-PYRIMIDO {1,2-A) PYRIMIDIN-6-ONE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AS AKT PHOSPHORYLATION INHIBITORS (PKB) |
RS53317B (en) | 2009-07-02 | 2014-10-31 | Sanofi | Novel (6-oxo-1,6-dihydro-pyrimidin-2-yl)amide derivatives, prepration thereof, and pharmaceutical use thereof as akt phosphorylation inhibitors |
AR077628A1 (en) | 2009-07-02 | 2011-09-14 | Sanofi Aventis | DERIVATIVES OF 6- (MORFOLIN-4-IL) -PIRIMIDIN-4 (3H) -ONA, ITS PREPARATION AND ITS PHARMACEUTICAL USE AS INHIBITORS OF THE AKT PHOSPHORILATION (PKB) |
JP2013521002A (en) | 2010-03-05 | 2013-06-10 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | Induced dendritic cell composition and use thereof |
US9248110B2 (en) * | 2010-03-18 | 2016-02-02 | Steven Lehrer | Compositions and methods of treating and preventing lung cancer and lymphangioleiomyomatosis |
US8987272B2 (en) | 2010-04-01 | 2015-03-24 | Critical Outcome Technologies Inc. | Compounds and method for treatment of HIV |
FR2969613B1 (en) * | 2010-12-23 | 2013-02-08 | Sanofi Aventis | NOVEL 1,2,3,4-TETRAHYDRO-PYRIMIDO {1,2-A} PYRIMIDIN-6-ONE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE |
SI2655375T1 (en) | 2010-12-23 | 2015-03-31 | Sanofi | Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof |
FR2969612B1 (en) * | 2010-12-23 | 2013-02-08 | Sanofi Aventis | NOVEL 2,3-DIHYDRO-1H-IMIDAZO {1,2-A} PYRIMIDIN-5-ONE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE |
LT2658844T (en) | 2010-12-28 | 2017-02-10 | Sanofi | Novel pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors |
FR2969608B1 (en) * | 2010-12-28 | 2013-02-08 | Sanofi Aventis | NOVEL (5-HALO-6-OXO-1,6-DIHYDRO-PYRIMIDIN-2-YL) -AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AS AKT PHOSPHORYLATION INHIBITORS (PKB) |
FR2969614A1 (en) * | 2010-12-28 | 2012-06-29 | Sanofi Aventis | New pyrimidinone compounds are akt phosphorylation inhibitors useful for treating e.g. gastric cancer, glioblastomas, thyroid cancer, bladder cancer, breast cancer, melanoma, lymphoid or myeloid hematopoietic tumors, and sarcomas |
FR2969607B1 (en) * | 2010-12-28 | 2013-02-08 | Sanofi Aventis | NOVEL THIOPYRIMIDINONE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AS PHOSPHORYLATION INHIBITORS OF AKT (PKB) |
FR2969610B1 (en) * | 2010-12-28 | 2013-04-05 | Sanofi Aventis | NOVEL (6-OXO-1,6-DIHYDRO-PYRIMIDIN-2-YL) -INDOLINAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AS AKT PHOSPHORYLATION INHIBITORS (PKB) |
FR2992316A1 (en) | 2012-06-22 | 2013-12-27 | Sanofi Sa | PYRIMIDINONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
FR2992314B1 (en) | 2012-06-22 | 2015-10-16 | Sanofi Sa | NOVEL 2,3-DIHYDRO-1H-IMIDAZO {1,2-A} PYRIMIDIN-5-ONE AND 1,2,3,4-TETRAHYDRO-PYRIMIDO {1,2-A} PYRIMIDIN-6-ONE DERIVATIVES COMPRISING A SUBSTITUTED MORPHOLINE, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4661592A (en) * | 1984-06-27 | 1987-04-28 | G. D. Searle & Co. | 4H-pyrimido[2,1-a]isoquinolin-4-one derivatives |
US20070112005A1 (en) * | 2005-11-17 | 2007-05-17 | Xin Chen | Fused bicyclic mTOR inhibitors |
-
2008
- 2008-05-24 WO PCT/US2008/064809 patent/WO2008148074A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4661592A (en) * | 1984-06-27 | 1987-04-28 | G. D. Searle & Co. | 4H-pyrimido[2,1-a]isoquinolin-4-one derivatives |
US20070112005A1 (en) * | 2005-11-17 | 2007-05-17 | Xin Chen | Fused bicyclic mTOR inhibitors |
Also Published As
Publication number | Publication date |
---|---|
WO2008148074A2 (en) | 2008-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008148074A3 (en) | Inhibitors of mtor and methods of treatment using same | |
WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
WO2007087068A3 (en) | Inhibitors of tyrosine kinases and uses thereof | |
WO2012062925A3 (en) | Compounds and methods for treating pain | |
WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
EA200901486A1 (en) | COMPOUNDS AND COMPOSITIONS AS C-KIT AND PDGFR KINASE INHIBITORS | |
IL225198A (en) | Aminotetrahydropyran compounds, pharmaceutical compositions comprising the same and the use thereof for the treatment of diabetes | |
WO2008070016A3 (en) | Inhibitors of akt activity | |
EP2045251A4 (en) | Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses | |
WO2006135627A3 (en) | Inhibitors of akt activity | |
WO2006091395A3 (en) | Inhibitors of akt activity | |
MX344238B (en) | Tetrazole compounds and methods of making and using same. | |
MX2009006704A (en) | New compounds. | |
WO2012046030A3 (en) | Phosphodiesterase inhibitors | |
WO2006110638A3 (en) | Inhibitors of akt activity | |
WO2008076954A3 (en) | Heterocycle compounds and methods of use thereof | |
ZA201004214B (en) | Dipeptidyl peptidase-iv inhibiting compounds,methods of preparing the same,and pharmaceutical compositions containing the same as active agent | |
WO2011113060A3 (en) | Antiviral compounds and methods of use thereof | |
WO2006020680A3 (en) | Heterocyclic compounds as pharmaceutical agents | |
IL177366A0 (en) | Substituted azetidine compounds as cyclooxygease-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments | |
WO2008097924A3 (en) | Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders | |
WO2010121164A3 (en) | 1,4-benzodiazepinone compounds and their use in treating cancer | |
EA200901484A1 (en) | COMPOUNDS AND COMPOSITIONS AS C-KIT AND PDGFR KINASE INHIBITORS | |
ATE522500T1 (en) | AMIDE DERIVATIVES AS ION CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08756262 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08756262 Country of ref document: EP Kind code of ref document: A2 |